Zdrowie i gospodarka · 03/09/2014
FDA Classifies EGR1 Gene FISH Test System for Specimen Characterization into Class II with Special Controls
The FDA has classified the early growth response 1 (EGR1) gene fluorescence in-situ hybridization (FISH) test system for specimen characterization into Class II, requiring special controls to ensure the device's safety and effectiveness.
Source: Federal Register — Food and Drug AdministrationOpen original release →